Optical Biosystems, Inc. – Trademark Portfolio

Entity Type: 03

Optical Biosystems, Inc. holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 8 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 4 Nice Classification classes. The owner is based in Santa Clara, CA.

2255 Martin Avenue, Suite F

Santa Clara, CA 95050

8 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Optical Biosystems, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (8 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

1
Chemicals (4 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

42
Computer & Scientific (3 filings)

Scientific and technological services; industrial analysis and research services

45
Legal & Security Services (3 filings)

Legal services; security services for the protection of property and individuals

Frequently Asked Questions

How many trademarks does Optical Biosystems, Inc. have?

Optical Biosystems, Inc. has 8 U.S. trademarks filed with the USPTO.

What trademark classes does Optical Biosystems, Inc. file in?

Optical Biosystems, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What is Optical Biosystems, Inc.'s trademark registration success rate?

Optical Biosystems, Inc. has a 0% trademark registration rate, with 0 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.